Invesaro

Stocks Comparison

Bio-Rad Laboratories vs Waters: revenue, profit, margins and growth compared

Bio-Rad Laboratories brought in $2.6B of revenue in fiscal 2025, Waters $3.2B in fiscal 2025. Revenue changed by +0.7% at Bio-Rad Laboratories and +7.0% at Waters on the year before, so Waters grew faster. Bio-Rad Laboratories kept 29.4% of its revenue as net profit, Waters 20.3%. Free cash flow was $374.6M at Bio-Rad Laboratories and $539.8M at Waters.

Side by side, latest fiscal year

BIOWAT
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.6B$3.2B
Revenue growth+0.7%+7.0%
Net income$759.9M$642.6M
Net margin29.4%20.3%
Free cash flow$374.6M$539.8M
Free cash flow margin14.5%17.1%
Earnings per share (diluted)$27.85$10.76
Cash$529.8M$588M
Debt$1.2B$1.4B
Price to earnings13.740.3
Market value$10.2B$42.6B
Dividend yieldn/an/a
Rank by revenue in sector#194 of 451 · Industrials#176 of 451 · Industrials

Over the years

Revenue
BIO FY2018: $2.3BBIO FY2019: $2.3BBIO FY2020: $2.5BBIO FY2021: $2.9BBIO FY2022: $2.8BBIO FY2023: $2.7BBIO FY2024: $2.6BBIO FY2025: $2.6BWAT FY2018: $2.4BWAT FY2019: $2.4BWAT FY2020: $2.4BWAT FY2021: $2.8BWAT FY2022: $3BWAT FY2023: $3BWAT FY2024: $3BWAT FY2025: $3.2BFY18FY19FY20FY21FY22FY23FY24FY25
BIO $2.6BWAT $3.2B
Net income
BIO FY2018: $365.6MBIO FY2019: $1.8BBIO FY2020: $3.8BBIO FY2021: $4.3BBIO FY2022: -$3.6BBIO FY2023: -$637.3MBIO FY2024: -$1.8BBIO FY2025: $759.9MWAT FY2018: $593.8MWAT FY2019: $592.2MWAT FY2020: $521.6MWAT FY2021: $692.8MWAT FY2022: $707.8MWAT FY2023: $642.2MWAT FY2024: $637.8MWAT FY2025: $642.6MFY18FY19FY20FY21FY22FY23FY24FY25
BIO $759.9MWAT $642.6M
Net margin
BIO FY2018: 16.0%BIO FY2019: 76.1%BIO FY2020: 149.8%BIO FY2021: 145.6%BIO FY2022: -129.5%BIO FY2023: -23.9%BIO FY2024: -71.9%BIO FY2025: 29.4%WAT FY2018: 24.5%WAT FY2019: 24.6%WAT FY2020: 22.1%WAT FY2021: 24.9%WAT FY2022: 23.8%WAT FY2023: 21.7%WAT FY2024: 21.6%WAT FY2025: 20.3%FY18FY19FY20FY21FY22FY23FY24FY25
BIO 29.4%WAT 20.3%
Revenue growth
BIO FY2019: +1.0%BIO FY2020: +10.1%BIO FY2021: +14.8%BIO FY2022: -4.1%BIO FY2023: -4.7%BIO FY2024: -3.9%BIO FY2025: +0.7%WAT FY2019: -0.6%WAT FY2020: -1.7%WAT FY2021: +17.8%WAT FY2022: +6.7%WAT FY2023: -0.5%WAT FY2024: +0.1%WAT FY2025: +7.0%FY19FY20FY21FY22FY23FY24FY25
BIO +0.7%WAT +7.0%
Free cash flow
BIO FY2018: $155.7MBIO FY2019: $359.4MBIO FY2020: $476.4MBIO FY2021: $535.7MBIO FY2022: $81.6MBIO FY2023: $218.2MBIO FY2024: $289.6MBIO FY2025: $374.6MWAT FY2023: $442.2MWAT FY2024: $619.6MWAT FY2025: $539.8MFY18FY19FY20FY21FY22FY23FY24FY25
BIO $374.6MWAT $539.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about Bio-Rad Laboratories and Waters

Which is bigger by revenue, Bio-Rad Laboratories or Waters?

Waters is bigger by revenue: $3.2B in fiscal 2025, against $2.6B for Bio-Rad Laboratories in fiscal 2025.

Which keeps more of its revenue as profit, Bio-Rad Laboratories or Waters?

Bio-Rad Laboratories had a net margin of 29.4% in fiscal 2025; Waters had 20.3% in fiscal 2025.

Which grew revenue faster, Bio-Rad Laboratories or Waters?

In their latest fiscal years revenue changed by +0.7% at Bio-Rad Laboratories and +7.0% at Waters.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies